Nanostructured lipid carriers as oral delivery systems for poorly soluble drugs

被引:67
作者
Beloqui, Ana [1 ]
del Pozo-Rodriguez, Ana [2 ]
Isla, Arantxazu [2 ]
Rodriguez-Gascon, Alicia [2 ]
Angeles Solinis, Maria [2 ]
机构
[1] Catholic Univ Louvain, Louvain Drug Res Inst, Adv Drug Delivery & Biomat, B-1200 Brussels, Belgium
[2] Univ Basque Country, Pharmacokinet Nanotechnol & Gene Therapy Grp Phar, Fac Pharm, UPV EHU,Lascaray Res Ctr, Paseo Univ 7, Vitoria 01006, Spain
关键词
Nanostructured lipid carriers; Poor water soluble drugs; Oral drug delivery; Bioavailability; Hot high-pressure homogenization; Inflammatory bowel diseases; OF-THE-ART; BIOAVAILABILITY ENHANCEMENT; IN-VIVO; PHYSICOCHEMICAL CHARACTERIZATION; FORMULATION DEVELOPMENT; GASTROINTESTINAL MUCUS; INTESTINAL BARRIER; NANOPARTICLES SLN; LIPOPHILIC DRUGS; PHARMACOKINETICS;
D O I
10.1016/j.jddst.2017.06.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Poorly water soluble (PWS) drugs lack from good oral absorption, which limits their oral administration, the most common drug delivery route. The design of appropriate innovative formulations for PWS drugs will allow for adequate bioavailability, reduction of the required dose and oral delivery of drugs that would otherwise need the parenteral route. Among the formulations under study, Nanostructured Lipid Carriers (NLCs), made of biocompatible mixtures of solid and liquid lipids, represent a good choice. NLCs enhance the apparent solubility and dissolution of PWS drugs in the gastrointestinal tract, and/or modulate the drug permeability and fate across the intestinal barrier, opening new perspectives in the field of innovative medicines for oral administration of PWS molecules. Recently, NLCs have also emerged as a promising anti-inflammatory drug delivery system for inflammatory bowel diseases. The present paper is focused on the state of the art of NLCs for oral delivery of PWS drugs. The design, the main preparation techniques and the mechanisms through the drug oral delivery is improved by NLCs are presented, highlighting the influence of the most relevant technological and formulation factors on the properties of the NLCs, which condition their efficacy as oral delivery formulations. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:144 / 154
页数:11
相关论文
共 89 条
  • [1] Optimizing Oral Bioavailability in Drug Discovery: An Overview of Design and Testing Strategies and Formulation Options
    Aungst, Bruce J.
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (04) : 921 - 929
  • [2] Solid lipid nanoparticles formed by solvent-in-water emulsion-diffusion technique: Development and influence on insulin stability
    Battaglia, Luigi
    Trotta, Michele
    Gallarate, Marina
    Carlotti, M. Eugenia
    Zara, Gian Paolo
    Bargoni, Alessandro
    [J]. JOURNAL OF MICROENCAPSULATION, 2007, 24 (07) : 672 - 684
  • [3] Lipid nanoparticles: state of the art, new preparation methods and challenges in drug delivery
    Battaglia, Luigi
    Gallarate, Marina
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2012, 9 (05) : 497 - 508
  • [4] Biodistribution of Nanostructured Lipid Carriers (NLCs) after intravenous administration to rats: Influence of technological factors
    Beloqui, A.
    Solinis, M. A.
    Delgado, A.
    Evora, C.
    del Pozo-Rodriguez, A.
    Rodriguez-Gascon, A.
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 84 (02) : 309 - 314
  • [5] Targeting Inflammatory Bowel Diseases by Nanocarriers Loaded with Small and Biopharmaceutical Anti-Inflammatory Drugs
    Beloqui, Ana
    Coco, Regis
    Preat, Veronique
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (40) : 6192 - 6206
  • [6] A Mechanistic Study on Nanoparticle-Mediated Glucagon-Like Peptide-1 (GLP-1) Secretion from Enteroendocrine L Cells
    Beloqui, Ana
    Alhouayek, Mireille
    Carradori, Dario
    Vanvarenberg, Kevin
    Li, Giulio G. Mucci
    Cani, Patrice D.
    Preat, Veronique
    [J]. MOLECULAR PHARMACEUTICS, 2016, 13 (12) : 4222 - 4230
  • [7] Mechanisms of transport of polymeric and lipidic nanoparticles across the intestinal barrier
    Beloqui, Ana
    des Rieux, Anne
    Preat, Veronique
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2016, 106 : 242 - 255
  • [8] A comparative study of curcumin-loaded lipid-based nanocarriers in the treatment of inflammatory bowel disease
    Beloqui, Ana
    Memvanga, Patrick B.
    Coco, Regis
    Reimondez-Troitino, Sonia
    Alhouayek, Mireille
    Muccioli, Giulio G.
    Alonso, Maria Jose
    Csaba, Noemi
    de la Fuente, Maria
    Preat, Veronique
    [J]. COLLOIDS AND SURFACES B-BIOINTERFACES, 2016, 143 : 327 - 335
  • [9] Nanostructured lipid carriers: Promising drug delivery systems for future clinics
    Beloqui, Ana
    Angeles Solinis, Maria
    Rodriguez-Gascon, Alicia
    Almeida, Antonio J.
    Preat, Veronique
    [J]. NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2016, 12 (01) : 143 - 161
  • [10] Dextran-protamine coated nanostructured lipid carriers as mucuspenetrating nanoparticles for lipophilic drugs
    Beloqui, Ana
    Angeles Solinis, Maria
    des Rieux, Anne
    Preat, Veronique
    Rodriguez-Gascon, Alicia
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 468 (1-2) : 105 - 111